https://www.prnewswire.com/news-releases/noven-to-participate-in-annual-international-conference-on-adhd-chadd-301674128.html
/PRNewswire/ -- Noven Pharmaceuticals, Inc., ("Noven") a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. focusing on the development of...
Create an account or login to join the discussion